Glomerular hematuria and the utility of urine microscopy: a review
MK Saha, D Massicotte-Azarniouch… - American Journal of …, 2022 - Elsevier
Evaluation of hematuria and microscopic examination of urine sediment are commonly used
tools by nephrologists in their assessment of glomerular diseases. Certain morphological …
tools by nephrologists in their assessment of glomerular diseases. Certain morphological …
Treatment of rare inflammatory kidney diseases: drugs targeting the terminal complement pathway
M Anliker-Ort, J Dingemanse, J Van den Anker… - Frontiers in …, 2020 - frontiersin.org
The complement system comprises the frontline of the innate immune system. Triggered by
pathogenic surface patterns in different pathways, the cascade concludes with the formation …
pathogenic surface patterns in different pathways, the cascade concludes with the formation …
Clinical outcomes of patients with C3G or IC-MPGN treated with the factor D inhibitor danicopan: final results from two phase 2 studies
C Nester, GB Appel, AS Bomback… - American journal of …, 2022 - karger.com
Abstract Introduction: C3 glomerulopathy (C3G) is an ultrarare, chronic and progressive
nephropathy mediated by dysregulation of the alternative pathway of complement (AP), with …
nephropathy mediated by dysregulation of the alternative pathway of complement (AP), with …
Complement C3 Regulates Inflammatory Response and Monocyte/Macrophage Phagocytosis of Streptococcus agalactiae in a Teleost Fish
H Bai, L Mu, L Qiu, N Chen, J Li, Q Zeng, X Yin… - International Journal of …, 2022 - mdpi.com
The complement system is composed of a complex protein network and is pivotal to innate
immunity. Complement 3 (C3) is a critical protein in the complement cascade and …
immunity. Complement 3 (C3) is a critical protein in the complement cascade and …
Treatment of C3 glomerulopathy in adult kidney transplant recipients: a systematic review
Background: C3 glomerulopathy (C3G), a rare glomerular disease mediated by alternative
complement pathway dysregulation, is associated with a high rate of recurrence and graft …
complement pathway dysregulation, is associated with a high rate of recurrence and graft …
The role of the complement system in primary membranous nephropathy: A narrative review in the era of new therapeutic targets
Primary membranous nephropathy (MN) is an important cause of nephrotic syndrome and
chronic kidney disease (CKD) in the adult population. Although the discovery of different …
chronic kidney disease (CKD) in the adult population. Although the discovery of different …
Daratumumab in the treatment of C3 glomerulopathy with monoclonal gammopathy: a case report and literature review
P Esposito, D Picciotto, F Costigliolo, E Russo… - Frontiers in …, 2023 - frontiersin.org
Although rare, C3 glomerulopathy (C3G) is increasingly recognized thanks to the currently
available diagnostic skills. C3G is not a single disease but a group of disorders with distinct …
available diagnostic skills. C3G is not a single disease but a group of disorders with distinct …
Autoimmune diseases of the kidney
F Aqeel, SY Sorkhabi, H Rabb, D Geetha - The Rose and Mackay Textbook …, 2024 - Elsevier
This chapter discusses the pathogenesis of autoimmune diseases that affect the kidneys.
The human immune system has the ability to distinguish self and nonself antigens via a …
The human immune system has the ability to distinguish self and nonself antigens via a …
[PDF][PDF] Clinical research advances of CFHR5 nephropathy: a recent review.
ZG Fei, K Zhen, FJ Zhang, PY Liu… - European Review for …, 2023 - europeanreview.org
CFHR5 nephropathy is a type of clinical C3 glomerulopathy, which is a monogenic genetic
disease caused by the internal replication of CFHR5 gene, a protein related to the …
disease caused by the internal replication of CFHR5 gene, a protein related to the …
Expert Discussion on Challenges in C3G Diagnosis: A Podcast Article on Best Practices in Kidney Biopsies
RA Lafayette, V Charu - Advances in therapy, 2023 - Springer
Abstract Complement 3 glomerulopathy (C3G) is an ultra-rare, progressive kidney disease
resulting from dysregulation of the alternative complement pathway. Clinical presentation of …
resulting from dysregulation of the alternative complement pathway. Clinical presentation of …